The localization of prenylated Ras at the plasma membrane promotes activation of Ras by receptor tyrosine kinases and stimulates oncogenic signaling by mutant Ras. The Nogo-B receptor (NgBR) is a transmembrane receptor that contains a conserved hydrophobic pocket. Here, we demonstrate that the NgBR promotes the membrane accumulation of Ras by directly binding prenylated Ras at the plasma membrane. We show that NgBR knockdown diminishes the membrane localization of Ras in multiple cell types. NgBR overexpression in NIH-3T3 fibroblasts increases membrane-associated Ras, induces the transformed phenotype in vitro, and promotes the formation of fibrosarcoma in nude mice. NgBR knockdown in human breast cancer cells reduces Ras membrane localization, inhibits epidermal growth factor (EGF)-stimulated Ras signaling and diminishes tumorigenesis of xenografts in nude mice. Our data demonstrate that NgBR is a unique receptor that promotes accumulation of prenylated Ras at the plasma membrane and promotes EGF pathways. HIGHLIGHTS 1. A conceptual advance of the mechanisms controlling membrane localization of Ras. 2. NgBR is a cell surface protein with hydrophobic domains. 3. NgBR binds farnesylated Ras and increases Ras membrane accumulation. 4. NgBR promotes Ras activation and Ras oncogenic signaling.
INTRODUCTION
Ras GTPases and their mutants are well-characterized oncogenes causing cell transformation and tumorigenesis. [1] [2] [3] The events that promote membrane localization of these GTPases have translational importance, because oncogenic signaling by these small GTPases depends on their interactions with regulators and effectors at the plasma membrane. 4, 5 Galectin-1 and galectin-3 are cytosolic proteins with hydrophobic farnesyl-binding pockets that strengthen the association of guanosine triphosphate (GTP)bound H-Ras and K-Ras at the plasma membrane in association with non-lipid raft subdomains. [6] [7] [8] Bindings of PDEδ is essential to maintain the subcellular localization of several farnesylated Ras variants. [9] [10] [11] Caveolin-1 acts as a membrane-docking site in lipid raft domains for binding guanosine diphosphate (GDP)-loaded H-Ras. [12] [13] [14] [15] [16] However, transmembrane proteins that act as docking sites in non-lipid raft domains for GDP/GTP-loaded H-Ras and K-Ras have not been identified. Here, we demonstrate that Nogo-B receptor (NgBR), a transmembrane receptor outside of caveolaerich lipid rafts, recruits both GDP-and GTP-bound H-Ras and K-Ras to the plasma membrane and is a major promoter of oncogenic signaling by these GTPases.
NgBR was identified as a receptor specific for Nogo-B, 17 and is involved in blood vessel development. [18] [19] [20] Genetic depletion of NgBR results in early-stage embryonic lethality. 18, 19 NgBR also is highly expressed in late stages of invasive ductal carcinoma 21 and promotes the epithelial-mesenchymal transition of breast tumor cells 22 as well as the chemo-resistance of human hepatocellular carcinoma. 23 However, the underlying mechanism by which NgBR promotes endothelial cell migration and tumor cell growth is unknown. As discussed in our previous report, 17 the cytoplasmic domain of NgBR has a high degree of homology to the Cis-Isoprenyl Diphosphate Synthases family of lipid-modifying enzymes, which have conserved hydrophobic pockets for binding isoprenyl lipids and/or prenylated proteins. 24 Similar hydrophobic pockets occur in other proteins that bind prenylated GTPases, such as PEDδ 9,10 and RhoGDI. 25, 26 Our previous results showed that NgBR has negligible lipid transferase activity. 17 Here, we demonstrate that the hydrophobic cytoplasmic domain of NgBR acts as a docking site for binding prenylated Ras and promotes the plasma membrane accumulation and activation of both H-Ras and K-Ras. Our findings will facilitate further understanding of the mechanisms that localize and activate Ras GTPases at the plasma membrane.
RESULTS

NgBR binds farnesylated Ras and enhances Ras plasma membrane localization
As shown in Figure 1a , NgBR is sporadically distributed at the plasma membrane of non-permeabilized HeLa cells. Specific immunofluorescence staining was diminished at the plasma membrane when the HeLa cells were transfected with validated NgBR siRNA (Figure 1a ) or when the primary antibody was preincubated with blocking peptide (Supplementary Figure S1A , upper panel). NgBR were also detected in the cell surface protein fraction (Figure 1b, lane 5) isolated by the cell surface biotinylation approach. Interestingly, immunofluorescence staining indicated that NgBR can be partially co-localized with H-Ras and epidermal growth factor receptors (EGFR) at the plasma membrane ( Figure 1c ), but NgBR does not co-localize with caveolin-1 (Supplementary Figure S1B) . These results indicate that the NgBR is excluded from the caveolae-rich lipid raft domain of the plasma membrane. The localization of EGFP-H-Ras at the plasma membrane (Figure 1d left panel) was diminished by depletion of NgBR with siRNA, causing most of the EGFP-H-Ras to accumulate in the cytosolic compartment (Figure 1d , right panel). The distribution of EGFP fluorescence signal intensity across the three-dimensional reconstruction of the z-stack image is shown in Supplementary Figure S2 . The results clearly demonstrated that depletion of NgBR reduced the intensity of EGFP-H-Ras at the plasma membrane (Supplementary Figure S2 ). Quantitative imaging analysis indicated that EGFP-H-Ras was localized at the plasma membrane in 5% of the HeLa cells transfected with NgBR siRNA, compared with 480% of the HeLa cells transfected with non-targeting siRNA (Figure 1e ). Similarly, NgBR is also required for K-Ras translocation to the plasma membrane (Supplementary Figure S3A ). The RNAi-mediated depletion of NgBR in HeLa cells not only reduces plasma membrane localization of wild-type H-Ras, but also diminishes the membrane localization of the constitutively activated H-Ras mutant (H-Ras G12V) and dominant negative H-Ras mutant (H-Ras S17N) (Supplementary Figure S3B ). We found that depletion of NgBR does not diminish H-Ras farnesylation (Supplementary Figure S4A , lane 3), which is diminished by treatment with a farnesylation inhibitor (FTI277) (Supplementary Figure S4A , lane 5). As shown in Supplementary Figure S4B , NgBR knockdown in HeLa cells does not change the expression levels of either Caveolin-1 or Galectin-1 and -3. These results suggest that NgBR regulates Ras plasma membrane accumulation via a different mechanism independent of caveolin-1 and galectin-1/-3.
To assess the ability of NgBR to form a stable complex with H-Ras, we transfected either NgBR-human influenza hemagglutinin (HA) plasmid DNA to HEK293T cells (Figure 2a . NgBR is essential for H-Ras plasma membrane localization. (a) NgBR is localized in the plasma membrane of non-permeabilized HeLa cells. Immunofluorescence staining was performed using NgBR rabbit polyclonal antibody specially recognizing the ecto-domain of NgBR. (b) NgBR is detected in the fraction of biotinylated cell surface proteins. HeLa cell surface proteins were biotinylated under non-permeabilized conditions and isolated using streptavidin agarose resin from the Pierce Cell Surface Protein Isolation Kit. Proteins were detected by western blot analysis. Pan-Cadherin, Calreticulin and GS28 are plasma membrane, ER membrane and Golgi membrane markers, respectively. The plus symbol (+) denotes results for cells treated with the Sulfo-NHS-SS-Biotin reagent; the minus symbol ( − ) denotes results for cells that were not treated with the biotin reagent but were otherwise carried through the kit procedure. The lane designated 'R' shows control samples that were isolated in the absence of avidin-agarose resin, the lanes designated 'F' show proteins that flowed through the columns because they did not bind the avidin-agarose resin, and the lanes designated 'E' show proteins that were eluted from the columns after binding to the avidin-agarose resin. As expected, surface proteins bound to the avidin-agarose resin if the cells were labeled with biotin ('E' , lane 5), but surface proteins flowed through the columns if the cells were not labeled with biotin ('F' , lane 2). GTP-loaded Ras. 27 These results suggest that NgBR regulates H-Ras by forming a stable complex with H-Ras.
Farnesylation of the CAAX box of H-Ras is generally required for H-Ras to localize at the plasma membrane. 12, 28, 29 To elucidate whether NgBR directly binds farnesylated H-Ras, purified NgBR tagged with Maltose-binding protein (MBP-NgBR) was incubated with non-prenylated H-Ras (H-Ras-C186S, a mutation at the cysteine of CAAX box) or with farnesylated H-Ras. IP using anti-MBP magnetic beads indicated that MBP-NgBR forms strong complex with farnesylated H-Ras (Figure 2c, lane 7) , and the complex formation can be blocked using the farnesyl analogs N-Acetyl-S-farnesyl-L-cysteine-methyl-ester ( Figure 2c Figure S5A ) showed that several conserved hydrophobic residues, such as I117, L120, V122, are essential for binding farnesyl diphosphate, and that E262 are critical for maintaining the structure of the farnesyl group-binding pocket. [30] [31] [32] Site-directed mutagenesis of the three residues I117, L120 and V122 to alanine (designated the TM mutant) or E262 to alanine (E262A), but not L186 to alanine (L186A), diminished the ability of MBP-NgBR to form a stable complex with H-Ras-farn (Supplementary Figure S5B ). These results suggest that NgBR preferentially binds farnesylated H-Ras, and the hydrophobic residues at the carboxyl terminus of NgBR are critical for binding farnesylated Ras. The ability of endogenous NgBR to form a complex with the activated H-Ras is further indicated by pulldown assays with GST-Ras-binding domain beads (Figure 2d ). EGF stimulation in HeLa cells not only increases the activation of endogenous H-Ras, but also increases the amount of NgBR associated with the activated H-Ras (Figure 2d ). The specificity of NgBR for binding the activated H-Ras is validated by our finding that treatment with S-trans, trans-farnesylthiosalicylic acid, an inhibitor blocking translocation of farnesylated Ras to the plasma membrane, 33 diminishes the ability of endogenous NgBR to form a complex with endogenous H-Ras ( Figure 2d ). Taken together, Figure 2 . Prenylation of H-Ras is essential for NgBR-Ras interaction. (a) Endogenous Ras was detected in the complex of NgBR-HA immunoprecipitated from 293T cells transfected with NgBR-HA plasmid DNA. (b) Endogenous NgBR interacts with the constitutively activated H-Ras. Plasmid DNA of H-Ras-G12V mutant was transfected to HeLa cells. The complex of activated Ras (GTP-loaded Ras) was precipitated from the quiescent cells using GST-RBD beads. Protein levels were detected by western blotting. Both Ras and endogenous NgBR were detected in the complex precipitated by the Raf-pull-down method. (c) NgBR interacts with Ras directly in a cell-free system. AFCME: a farnesyl analog, N-Acetyl-S-farnesyl-L-cysteine-methyl ester. Protein levels were detected by western blotting. Purified MBP (maltose-binding protein)tagged NgBR (MBP-NgBR) was incubated with either unfarnesylated Ras (H-Ras-C186S, containing a mutation at the cysteine of CAAX box) or farnesylated Ras (H-Ras-Farn). The complex was immunoprecipitated using anti-MBP magnetic beads (New England BioLabs). (d) Blocking prenyl-dependent interactions of H-Ras diminishes its interactions with NgBR. HeLa cells were stimulated with 100 ng/ml EGF for 5 min. The complex of the GTP-loaded H-Ras was pulled down using GST-RBD beads. FTS pretreatment (20 μM for overnight) abolished the interaction of GTP-loaded H-Ras and NgBR. FTS: S-trans, trans-farnesylthiosalicylic acid. Data are validated in three independent experiments.
these findings demonstrate a strong interaction between NgBR and Ras that is dependent on Ras farnesylation.
The CAAX motif of H-Ras is critical for binding NgBR
To elucidate which domain of H-Ras is important for binding with NgBR, we examined the intracellular localization of EGFP fused to (1) the C-terminal 20 residues of H-Ras (H-RasC20), (2) full-length H-Ras that has its CAAX motif (CVLS) replaced with the RhoA CAAX motif (CLVL) (H-Ras-RhoA-CAAX) and (3) full-length H-Ras that has its aa 170-185 (klnppdesgpgcmsck) replaced with aa 170-185 of K-Ras constituting the polybasic region (mskdgkkkkkksktkc) (H-Ras-K-Ras-PBR). 3, [34] [35] [36] The diagram of these mutants is presented in Figure 3a . As shown in Figure 3b , EGFP-H-RasC20 localizes at the plasma membrane just as EGFP-H-Ras does (Figure 1d ). NgBR knockdown prevents the accumulation of EGFP-H-RasC20 at the plasma membrane, indicating that the interaction between NgBR and H-Ras is dependent on the C20 domain of H-Ras and independent of the N-terminal catalytic domain of H-Ras. We found that the H-Ras-RhoA-CAAX mutant that is geranylgeranylated also localizes at the plasma membrane, and this localization is diminished by NgBR knockdown, indicating that the NgBR can recruit geranylgeranylated GTPases just as it recruits farnesylated GTPases. Previous reports 37, 38 demonstrated that palmitoylation of C181 and C184 residues in H-Ras enhances H-Ras-binding affinity to lipid raft microdomains of the plasma membrane, and loss of palmitoylation results in the localization of H-Ras at intracellular compartments such as the Golgi. As shown in Figure 3b , the H-Ras-K-Ras-PBR mutant possessing the K-Ras PBR localizes at both the plasma membrane and Golgi/ER (endoplasmi reticulum) regions. NgBR knockdown significantly abolished the plasma membrane localization of H-Ras-K-Ras-PBR, but not the Golgi/ER location of H-Ras-K-Ras-PBR. This finding suggests that NgBR-regulated H-Ras plasma membrane translocation is dependent on prenylation of the CAAX motif but is independent of the palmitoylation of H-Ras. Collectively, these results indicate that NgBR binds prenylated Ras, which is critical for Ras plasma membrane accumulation.
NgBR overexpression promotes Ras membrane localization and recapitulates the tumorigenic functions of Ras GTPases
To further evaluate the plasma membrane localization of Ras by NgBR, we established an NIH-3T3 stable cell line overexpressing NgBR-HA. The localization of NgBR-HA in the plasma membrane of NIH-3T3-NgBR-HA cells was confirmed using a cell surface biotinylation assay. The levels of biotinylated NgBR in the cell surface fraction of NIH-3T3-NgBR-HA cells (Figure 4a , lane 9) are much higher than that in NIH-3T3 cells (Figure 4a , lane 5). The purity of the isolated cell surface membrane fraction was confirmed by no contamination of endoplasmic reticulum (Calreticulin) and Golgi (GS28) membrane proteins, respectively. As shown in Figure 4b , NgBR overexpression increases the levels of membrane-associated H-Ras and K-Ras without significantly increasing the total protein levels of H-Ras and K-Ras. NgBR overexpression does not increase the levels of membraneassociated pan-cadherin, indicating that the increased membrane association of Ras in NIH-3T3-NgBR-HA cells is not due to a general increase in membrane-associated proteins. The interaction between activated Ras and NgBR in NIH-3T3-NgBR-HA cells is shown in Supplementary Figure S6 . Activation of EGFRs in NIH-3T3-NgBR-HA cells increases the amount of NgBR being pulled down with H-Ras and K-Ras using GST-Ras-binding domain beads, most likely because EGF stimulates Ras activation at the plasma membrane as described in previous reports. 2, [39] [40] [41] As shown in Figure 4c , EGF-stimulated activation of both H-Ras and K-Ras significantly increases in NIH-3T3-NgBR-HA cells as compared with control NIH-3T3 cells. Consequently, overexpression of NgBR-HA enhances EGF-stimulated phosphorylation of Akt and extracellular signal-regulated kinase (ERK) in NIH-3T3 cells (Figure 4d ). However, overexpression of NgBR-HA does not increase the phosphorylation of EGFR (Supplementary Figure S7, lane 4) .
Like the typical functions of Ras overexpression such as transformation and tumorigenesis of NIH-3T3 cells as reported in previous publications, [42] [43] [44] NgBR overexpression transforms NIH-3T3 cells and significantly increases colony formation in soft agar, indicating anchorage-independent growth (Figures 5a and b) .
To determine the contribution of NgBR-mediated Ras recruitment to tumorigenesis, we determined the effects of NgBR mutants on the EGF-stimulated Ras activation and signaling. As shown in Supplementary Figure S7 Figure S8 ). To examine tumorigenesis in vivo, NIH-3T3 stable cells overexpressing either NgBR-HA or empty vector were injected subcutaneously into nude mice. After 8 weeks, tumors of various sizes appeared in eight mice receiving NIH-3T3-NgBR-HA cells but not in mice injected with control NIH-3T3 cells (Figure 5c ). Histological analysis showed that NgBR overexpression results in fibrosarcoma (Figure 5d ). These results demonstrate that NgBR overexpression increases membraneassociated Ras and promotes EGF-stimulated activation of Ras and its downstream kinases such as Akt and ERK. Importantly, NgBR overexpression in NIH-3T3 cells recapitulates the similar cellular functions of cell transformation and tumorigenesis that activated Ras induces. NgBR is essential for EGF signaling in breast cancer cells and contributes to the growth of breast tumor xenografts To elucidate the role of NgBR-mediated Ras recruitment in breast cancer cells, we examined the effects of NgBR knockdown on EGF signaling in MDA-MB-231 cells, an invasive breast carcinoma cell line. 45 As shown in Figure 6a , the levels of NgBR at the plasma membrane of MDA-MB-231 cells treated with NgBR siRNA was significantly reduced, which was determined using a cell surface biotinylation assay. NgBR knockdown in these MDA-MB-231 cells significantly reduced membrane-associated H-Ras and K-Ras, but did not change the levels of membrane protein pan-cadherin ( Figure 6b ). In addition, we established a subline of MDA-MB-231 cells with knockdown of NgBR by infecting the cells with lentivirus-mediated small hairpin interfering RNA (shRNA) targeting the 3'untranslated region of NgBR (shNgBR). Lentivirus carrying non-silencing (NS) shRNA was used as a negative control. As shown in Figure 6c , EGF stimulation robustly activated H-Ras and its preferred downstream kinase Akt, and NgBR knockdown significantly abolished the EGF-stimulated H-Ras activation and Akt phosphorylation. In contrast, EGF stimulation only moderately increased the ERK phosphorylation and K-Ras activation, and this response was not altered by NgBR knockdown (Supplementary Figure S9 ). These results might occur because MDA-MB-231 cells have constitutively activated K-Ras and Raf-1 mutants. 46, 47 We also examined the effects of NgBR knockdown on EGF-mediated signaling pathways in T24 bladder carcinoma cells, which have wild-type K-Ras and constitutively activated H-Ras. 48 As shown in Supplementary Figure S10 , the regulatory effects of NgBR in T24 cells are opposite to what happened in MDA-MB-231 cells. NgBR knockdown significantly abolished EGF-stimulated K-Ras activation and ERK phosphorylation, but had no inhibitory effects on H-Ras activation. In addition, we isolated primary cultured murine embryonic fibroblast cells from NgBR inducible knockout mice. NgBR knockout was induced by adding 4-hydroxy tamoxifen in the culture medium. As shown in Figure 6d , NgBR genetic knockout also inhibits EGF-stimulated H-Ras activation and Akt phosphorylation (Figure 6d, lane 6) . These findings strongly suggest that NgBR have diverse regulatory roles that are dependent on the status of H-Ras and K-Ras mutations in different types of carcinoma cells.
As shown in Supplementary Figures S11A and S11B , NgBR knockdown decreases colony formation of MDA-MB-231 cells. NgBR knockdown also moderately reduces the growth of MDA-MB-231 cells, as determined by the water-soluble tetrazolium salts-1 assay 49 (Supplementary Figure S11C ), but does not cause apoptosis ( Supplementary Figure S11D) , as determined by terminal deoxynucleotidyl transferase dUTP nick end labeling staining. 50 As a positive control, we detected terminal deoxynucleotidyl transferase dUTP nick end labeling staining in MDA-MB-231 cells treated with cisplatin ( Supplementary Figure S11D) . Wound-healing assays (Supplementary Figure S11E) indicated that NgBR knockdown does not significantly alter cell motility. 51 In summary, NgBR knockdown decreases the colony formation and cell growth of MDA-MB-231 cells.
To further evaluate the in vivo function of NgBR knockdown on breast tumor growth, we established NgBR inducible knockdown MDA-MB-231 stable cell lines using TRIPZ inducible lentivrial shRNA 52 (GE Dharmacon, Lafayette, CO, USA). As shown in Supplementary Figure S12 , doxycycline diminished the expression of NgBR in the shNgBR group (lanes 4 and 6) but not in the NS Figure S12B , upper panels). This finding demonstrates that doxycycline-induced specific knockdown of NgBR abolishes the in vitro malignant phenotype of MDA-MB-231 cells. We implanted the MDA-MB-231 cells carrying shNgBR in the flank region of nude mice. When tumors grew to the size of~200 mm 3 , the nude mice bearing the tumors were divided into two groups; one group was supplied with 1% sucrose drinking water and the other group was supplied with 1% sucrose drinking water plus 5% doxycycline for 3 weeks. Analysis of tumor size over 3 weeks (Figures 7a and b) indicated that the growth of the xenografts was slower in the mice given doxycycline. Real-time PCR analysis confirmed that NgBR transcript levels (Supplementary Figure S13A ) and protein levels ( Figure 7c) were decreased in the mice given doxycycline. Importantly, doxycycline administration diminished H-Ras activity in the tumor xenografts (Figures 7c and d) . Immunohistological analysis of the tumor xenografts demonstrate that doxycyclineinduced NgBR reduction (Figure 7e, right panel; Figure 7f ) reduced the number of cells staining positive for phosphorylated Akt, but did not have any significant effects on the phosphorylation of ERK in the tumor xenografts ( Supplementary Figure S13B) . These results demonstrated that NgBR promotes Ras plasma membrane accumulation in tumor cells and NgBR recapitulates the oncogenic function of Ras in cell transformation and tumor growth.
DISCUSSION
In this study, we demonstrate that the NgBR has a vital role in oncogenic signaling and malignant transformation induced by Ras GTPases by recruiting these GTPases to the plasma membrane. The three Ras isoforms (H-Ras, N-Ras and K-Ras) interact with receptor tyrosine kinases at the plasma membrane, but exhibit different abilities to activate downstream kinases such as phosphatidylinositol-3-OH kinase and Raf-1 kinase. 12, 39, 53 H-Ras preferentially activates phosphatidylinositol-3-OH kinase and is a weak activator for Raf-1, but K-Ras has the converse activation profile. 12, 54, 55 These functional differences have been attributed to the different locations of the Ras isoforms in distinct subdomains of the plasma membrane. 12, 53 Farnesylation and palmitoylation of H-Ras in the ER and Golgi, respectively, 56 target H-Ras to caveolaerich lipid rafts. 12, 14, 16, 38, 53 Activation of H-Ras redistributes it from lipid rafts into non-lipid raft regions, where H-Ras activates downstream kinases. [12] [13] [14] 53 In contrast, K-Ras is farnesylated but not palmitoylated, and is located outside lipid rafts irrespective of its activation status. 12, 14, 53 However, based on current models, 14, 15, 29 H-Ras traffics to lipid raft subdomains first and then re-distributes to non-lipid raft subdomains after H-Ras is activated and in the GTP-bound state. According to this model, only H-Ras that is in the GTP-bound state will be located in nonlipid raft subdomains. Somewhat surprisingly, our results indicate that the depletion of NgBR in the non-caveolae-rich lipid raft subdomain abolishes the majority of H-Ras plasma membrane localization. Based on findings 57,58 from the model membrane system that does not include NgBR, it indicates that NgBR is not required for the trafficking and nanoclusters of H-Ras in the lipidenriched plasma membrane. Thus, our findings suggest that NgBR is a novel binding partner that provides a docking site for GDP-or GTP-bound H-Ras outside of lipid rafts, contrary to current models proposing that only GTP-bound H-Ras localizes outside of lipid rafts. Further studies are needed to reconcile these findings with current models.
NgBR was initially identified as the receptor for Nogo-B. 17 High affinity of Nogo-B binding to NgBR is sufficient for Nogo-Bmediated chemotaxis 17 and is essential for developmental angiogenesis. [18] [19] [20] Recent reports also demonstrated that NgBR is involved in the epithelial-mesenchymal transition of breast tumor cells 22 and the resistance of human hepatocellular carcinoma to chemotherapy. 23 However, the underlying mechanism of NgBR signaling in cancer is still unclear. Analysis of the NgBR sequence reveals its C-terminal domain has high homology with cis-isoprenyltransferase (cis-IPTase). 17 Further studies revealed that NgBR is a critical subunit of cis-IPTase, which is involved in the synthesis of dolichol that is an intermediate product required for protein glycosylation. 59, 60 Our results demonstrate that the hydrophobic domain of NgBR binds farnesylated Ras independent of cis-IPTase because purified MBP-NgBR alone binds farnesylated H-Ras (Figure 2c) . Findings from our studies demonstrate that NgBRmediated Ras membrane accumulation may contribute to these identified roles of NgBR in tumor cells. 22, 23 Although Ras mutation rarely occurs in breast cancer (o 10%), 2,61 oncogenic signaling by Ras contributes to the tumorigenic and invasive potential of breast epithelial cells. 2, 62 Therefore, upregulation of normal Ras activity by receptor tyrosine kinases, such as the EGFR family, is a major focus for breast cancer research. 2, 62 Introduction of activated H-Ras into certain mouse or human breast epithelial cells results in acquisition of a transformed phenotype in vitro (such as increased anchorage independent growth) and in vivo, as shown by the ability to form tumors in nude mice. [63] [64] [65] In addition, a large number of clinical studies have demonstrated overexpression of Ras in breast cancers. [66] [67] [68] There is a significant trend for tumors to be lymph node positive with increasing expression of Ras proteins, and Ras overexpression is related to early disease recurrence and death in lymph node-negative patients. 68 Therefore, understanding how the Ras activation pathway is regulated in breast cancer cells will be critical for developing new therapeutic approaches. The EGFsignaling pathway is one of the major therapeutic targets for cancer therapy. 69, 70 As shown in Supplementary Figure S14 , EGF binds the EGFR to recruit RasGEFs such as SOS via its SHC domain and Grb2 adapter protein. 2, [39] [40] [41] Membrane-associated Ras is one of the critical substrates for activated EGFR and is required for further activation of both the PI3K-Akt and Raf1-ERK pathways, which contribute to tumorigenesis and tumor resistance. 40, 41 Our results showed NgBR overexpression in NIH-3T3 cells recapitulates the similar cellular functions of cell transformation and tumorigenesis that activated Ras induces. NgBR is essential for Ras plasma membrane accumulation in tumor cells and NgBR recapitulates the oncogenic function of Ras in cell transformation and tumor growth. Furthermore, we found that NgBR mainly regulates the EGF-stimulated activation of wild-type H-Ras and K-Ras because they must translocate to the plasma membrane to be activated by GEFs recruited by the EGFR. 2, 39, 71 It is possible that constitutively activated H-Ras and K-Ras can activate their downstream kinases not only at the plasma membrane but also at other cellular compartments such as the ER and Golgi. 29, 53 These results also suggest that NgBR is a novel therapeutic target for controlling Ras signaling mediated by many receptor tyrosine kinases such as EGF, fibroblast growth factor and vascular endothelial growth factor receptors.
MATERIALS AND METHODS
Tumor implantation
In total, 10 6 MDA-MB-231 shNgBR stable cells were subcutaneously implanted to the flank region of 6-8 weeks male nude mice (Charles River Laboratories, Wilmington, MA, USA). When the average tumor volume reached~200 mm 3 , mice were separated to two groups randomly and then fed with or without 2 mg/ml doxycycline in 1% sucrose drinking water. The diameters of the tumors were measured every other day with a caliper. The tumor volume was calculated as Tumor volume = 0.5 × length × width 2 . After 3 weeks of doxycycline administration, mice were killed and tumors were isolated. Half of the tumor tissues were fixed in 4% paraformaldehyde/phosphate-buffered saline for histology analysis and another half were frozen in liquid nitrogen for gene expression analysis. For NIH-3T3 cell implantation, 10 6 NIH-3T3 control cells or highly expressing NgBR-HA cells (NIH-3T3-NgBR-HA) were subcutaneously implanted to the flank region of 6-8 weeks male nude mice. After 6-8 weeks, mice were killed and tumor tissues were isolated as above described. Tumors from animals that died before the endpoint were excluded from the analysis. All of the animal experiments were approved by the Institutional Animal Care Use Committee of the Medical College of Wisconsin.
Data analysis
All in vitro experiments presented are representative and were replicated at least three times. Sample sizes for relevant experiments were determined by power analysis. The results of quantitative assays were analyzed using statistical software SPSS 16.0 for Windows. Data are presented as mean ± s.e.m. Barlett's test was performed prior to analysis of variance. The statistical significance of differences was evaluated with the analysis of variance followed by Dunnett's post hoc analysis. Significance was defined as Po0.05.
